The recent disruptions in global supply have highlighted the value of securing critical medications like Ivermectin. Trusting on overseas vendors exposes regions to potential vulnerabilities, including delivery delays, cost fluctuations, and even trade risks. Shifting towards domestic procurement of Ivermectin offers a multitude of upsides. Initial